About Digital Life Line

Accurate, convenient early screening — anywhere.

Company story

Who we are

Digital Life Line is a Singapore-based, ISO 13485-certified medical technology company. It combines clinical expertise, global manufacturing know-how, and regulatory proficiency to rapidly bring to market diagnostics that enable accurate and convenient early screening.

The company works with renowned institutions in Singapore to accelerate the commercialization of best-in-class, highly de-risked breakthroughs.

Incorporated on 29 November 2021, Digital Life Line operates as a developer of diagnostic devices for multiple diseases. Its current focus is on accurate vision screening devices that can be performed by patients with minimal supervision, decentralizing eye screening and disease monitoring.

Timeline

Milestones

  1. Incorporated; developer of diagnostic devices for multiple diseases.

  2. AVAT deployed at the National University Hospital ophthalmology clinic in Singapore.

Partnerships

Collaborations

Digital Life Line works with renowned institutions in Singapore to accelerate the commercialization of best-in-class, highly de-risked breakthroughs.

Leadership

Our people

Board of Directors

Professor Soo Khee Chee

Professor Soo Khee Chee

Chairman

In 1997 he became the Founding Director of the National Cancer Centre Singapore and recently retired from that position after 20 years.

Dr. Chua Lee Kiang, Melvin

Dr. Chua Lee Kiang, Melvin

Director

Dr Melvin Chua is a Clinician-Scientist at the National Cancer Centre Singapore.

Chng Weng Wah, Eddie

Chng Weng Wah, Eddie

Managing Director and Group Chief Executive Officer

Eddie is currently the Managing Director of DISA Limited, overseeing DISA's growth.

John Wong Weng Foo

John Wong Weng Foo

Director

Mr. Wong was a General Partner at General Atlantic Partners, a worldwide private equity firm.

Han Yang Kwang

Han Yang Kwang

Executive Director

Yang Kwang is the Chief Executive Officer of Digital Life Line.

Chief Scientist

Dr. Poh Weijie

Dr. Poh Weijie, PhD

Chief Scientist/Chief Scientific Officer

Dr. Poh has a Ph.D. in Pathobiology from the Johns Hopkins University and completed his postdoctoral training at Harvard Medical School.

Chief Engineer

Muhammad Azri

Muhammad Azri

Chief Engineer

Medical device innovator bridging clinical ophthalmology, AI, and agentic infrastructure. Expert in rapid prototyping, secure deployment, regulatory compliance, and agentic coding for complex projects.

Contact

Get in touch

Email us at [email protected].

Telephone
+65 6255 4905
Singapore office
120 Lower Delta Rd #03-15, Cendex Centre, Singapore 169208